Securities Registration (ads, Delayed) (f-6)

 

As filed with the Securities and Exchange Commission on April 9, 2020

Registration No. 333  -

 

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________________

 

FORM F-6

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933 FOR AMERICAN DEPOSITARY SHARES EVIDENCED BY

AMERICAN DEPOSITARY RECEIPTS

___________

 

hypera S.A.

(Exact name of issuer of deposited securities as specified in its charter)

___________

 

[N/A]

(Translation of issuer’s name into English)

___________

 

Federative Republic of Brazil

(Jurisdiction of incorporation or organization of issuer)

______________________________

 

CITIBANK, N.A.

(Exact name of depositary as specified in its charter)

___________

 

388 Greenwich Street

New York, New York 10013

[phone]

(Address, including zip code, and telephone number, including area code, of depositary’s principal executive offices)

___________

 

Puglisi & Associates

850 Library Avenue, Suite 204

Newark, Delaware 19711

Telephone: [phone]

(Address, including zip code, and telephone number, including area code, of agent for service)

______________________________

 

Copies to: 

Manuel Garciadiaz, Esq. Davis Polk & Wardwell LLP 450 Lexington Ave. New York, New York 10017 [phone]

Herman H. Raspé, Esq. Patterson Belknap Webb & Tyler LLP 1133 Avenue of the Americas New York, New York 10036 [phone]

______________________________

 

It is proposed that this filing become effective under Rule 466:	☐	immediately upon filing.
	☐	on (Date) at (Time).

 

If a separate registration statement has been filed to register the deposited shares, check the following box: ☐

 

CALCULATION OF REGISTRATION FEE

 

Title of Each Class of  Securities to be Registered	Amount to be  Registered	Proposed Maximum  Aggregate Price Per Unit*	Proposed Maximum  Aggregate Offering Price**	Amount of Registration Fee
American Depositary Shares (ADS(s)), each ADS representing the right to receive one (1) common share of Hypera S.A. (the “Company”)	100,000,000 ADSs	$5.00	$5,000,000	$649.00

 

*

Each unit represents 100 ADSs.

**

Estimated solely for the purpose of calculating the registration fee. Pursuant to Rule 457(k), such estimate is computed on the basis of the maximum aggregate fees or charges to be imposed in connection with the issuance of ADSs.

 

 

The Registrant hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, or until this Registration Statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

 

 

This Registration Statement may be executed in any number of counterparts, each of which shall be deemed an original, and all of such counterparts together shall constitute one and the same instrument.

 

ii

 

PART I

 

INFORMATION REQUIRED IN PROSPECTUS

 

Cross Reference Sheet

 

Item 1.

DESCRIPTION OF SECURITIES TO BE REGISTERED

 

Item Number and Caption				Location in Form of American Depositary Receipt (“Receipt”) Filed Herewith as Prospectus
1.	Name of Depositary and address of its principal executive office			Face of Receipt -  Introductory Article.
2.	Title of Receipts and identity of deposited securities			Face of Receipt  - Top Center and introductory paragraph.
	Terms of Deposit:
	(i)	The amount of deposited securities represented by one American Depositary Share (“ADSs”)		Face of Receipt  - Upper right corner and introductory paragraph.
	(ii)	The procedure for voting, if any, the deposited securities		Reverse of Receipt  - Paragraphs (15), (16), and (19).
	(iii)	The collection and distribution of dividends		Face of Receipt- Paragraph (10). Reverse of Receipt - Paragraphs (14), (15), (17), and (22).
	(iv)	The transmission of notices, reports and proxy soliciting material		Face of Receipt - Paragraph (13). Reverse of Receipt - Paragraphs (13), (15), (16), (20), (21), and (22).
	(v)	The sale or exercise of rights		Face of Receipt - Paragraph (10). Reverse of Receipt – Paragraphs (14) and (17).
	(vi)	The deposit or sale of securities resulting from dividends, splits or plans of reorganization		Face of Receipt - Paragraphs (3), (4), and (10); Reverse of Receipt - Paragraphs (15) and (17).

 

I-1

 

Item Number and Caption				Location in Form of American Depositary Receipt (“Receipt”) Filed Herewith as Prospectus
	(vii)	Amendment, extension or termination of the deposit agreement		Reverse of Receipt - Paragraphs (21) and (22) (no provision for extensions).
	(viii)	Rights of holders of Receipts to inspect the transfer books of the Depositary and the list of holders of ADSs		Face of Receipt - Paragraph (13).
	(ix)	Restrictions upon the right to deposit or withdraw the underlying securities		Face of Receipt – Paragraphs (2), (3), (4), (7), (9) and (10).
	(x)	Limitation upon the liability of the Depositary		Face of Receipt - Paragraph (7). Reverse of Receipt - Paragraphs (19) and (20).
3.	Fees and charges which may be imposed directly or indirectly on holders of ADSs			Face of Receipt - Paragraphs (7) and (10).
Item 2.		AVAILABLE INFORMATION		Face of Receipt - Paragraph (13).

 

The Company publishes the information contemplated in Rule 12g3-2(b)(2)(i) under the United States Securities Exchange Act of 1934, as amended (the “Exchange Act”) on its internet website or through an electronic information delivery system generally available to the public in the Company’s primary trading market. As of the date hereof the Company’s internet website is https://www.hyperapharma.com.br/index.php?lang=en_us. The information so published by the Company may not be in English, except that the Company is required, in order to maintain its exemption from the Exchange Act reporting obligations pursuant to Rule 12g3-2(b), to translate such information into English to the extent contemplated in Rule 12g3-2(b). The information so published by the Company cannot be retrieved from the internet website of United States Securities and Exchange Commission (the “Commission”), and cannot be inspected or copied at the public reference facilities maintained by the Commission located (as of the date of the Amended and Restated Deposit Agreement) at 100 F Street, N.E., Washington, D.C. 20549.

 

I-2

 

PROSPECTUS

 

The Prospectus consists of the proposed form of American Depositary Receipt included as Exhibit A to the Form of Amended and Restated Deposit Agreement filed as Exhibit (a) to this Registration Statement on Form F-6 and is incorporated herein by reference.

 

I-3

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

Item 3.

EXHIBITS

 

(a)

Form of Amended and Restated Deposit Agreement, by and among Hypera S.A. (the “Company”), Citibank, N.A., as depositary (the “Depositary”), and all Holders and Beneficial Owners of American Depositary Shares issued thereunder (“Deposit Agreement”). — Filed herewith as Exhibit (a).

 

(b)

Any other agreement to which the Depositary is a party relating to the issuance of the American Depositary Shares registered hereunder or the custody of the deposited securities represented thereby. — None.

 

(c)

Every material contract relating to the deposited securities between the Depositary and the issuer of the deposited securities in effect at any time within the last three years. — None.

 

(d)

Opinion of counsel for the Depositary as to the legality of the securities to be registered. — Filed herewith as Exhibit (d).

 

(e)

Certificate under Rule 466. — None.

 

(f)

Powers of Attorney for certain officers and directors and the authorized representative of the Company. — Set forth on the signature pages hereto.

 

II-1

 

Item 4.

UNDERTAKINGS

 

(a)

The Depositary undertakes to make available at the principal office of the Depositary in the United States, for inspection by holders of ADSs, any reports and communications received from the issuer of the deposited securities which are both (1) received by the Depositary as the holder of the deposited securities, and (2) made generally available to the holders of the underlying securities by the issuer.

 

(b)

If the amount of fees charged is not disclosed in the prospectus, the Depositary undertakes to prepare a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver promptly a copy of such fee schedule without charge to anyone upon request. The Depositary undertakes to notify each registered holder of an ADS thirty (30) days before any change in the fee schedule.

 

II-2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, Citibank, N.A., acting solely on behalf of the legal entity to be created by the Amended and Restated Deposit Agreement, by and among Hypera S.A., Citibank, N.A., as depositary, and all Holders and Beneficial Owners from time to time of American Depositary Shares to be issued thereunder, certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Registration Statement on Form F-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on the 9^th day of April, 2020.

 

	Legal entity created by the Amended and Restated Deposit Agreement under which the American Depositary Shares registered hereunder are to be issued, each American Depositary Share representing the right to receive one (1) common share of Hypera S.A.
	CITIBANK, N.A., solely in its capacity as Depositary
	By:	/s/ Leslie A. DeLuca
	Name:	Leslie A. DeLuca
	Title:	Vice President

 

II-3

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, Hypera S.A. certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Registration Statement on Form F-6 to be signed on its behalf by the undersigned thereunto duly authorized, in Sao Paulo, Brazil, on March 6, 2020.

 

	HYPERA S.A.
	By:	/s/ Adalmario Ghovatto Satheler do Couto
		Name: Adalmario Ghovatto Satheler do Couto
		Title: Chief Financial Officer
	By:	/s/ Rafael Vito Batista
		Name: Rafael Vito Batista
		Title: Diretor (Officer)

 

II-4

 

POWERS OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints each of Breno Toledo Pires de Oliveira and Adalmario Ghovatto Satheler do Couto to act as his/her true and lawful attorney-in-fact and agent, with full power of substitution, for him/her and in his/her name, place and stead, in any and all such capacities, to sign any and all amendments, including post-effective amendments, and supplements to this Registration Statement, and to file the same, with all exhibits thereto and other documents in connection therewith, with the United States Securities and Exchange Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as s/he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his/her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement on Form F-6 has been signed by the following persons in the following capacities on March 6, 2020.

 

Signature		Title
/s/ Breno Toledo Pires de Oliveira		Chief Executive Officer and Member of Board of Directors
Breno Toledo Pires de Oliveira		(Principal Executive Officer)
/s/ Adalmario Ghovatto Satheler do Couto		Chief Financial Officer
Adalmario Ghovatto Satheler do Couto		(Principal Financial & Accounting Officer)
/s/ Álvaro Stainfeld Link		Chairman of Board of Directors
Álvaro Stainfeld Link
/s/ Bernardo Malpica Hernández		Member of Board of Directors
Bernardo Malpica Hernández
/s/ David Coury Neto		Member of Board of Directors
David Coury Neto
/s/ Esteban Malpica Fomperosa		Member of Board of Directors
Esteban Malpica Fomperosa
/s/ Flair José Carrilho		Member of Board of Directors
Flair José Carrilho

 

II-5

 

Signature		Title
/s/ Hugo Barreto Sodré Leal		Member of Board of Directors
Hugo Barreto Sodré Leal
/s/ Luciana Cavalheiro Fleischner Alves de Queiroz		Member of Board of Directors
Luciana Cavalheiro Fleischner Alves de Queiroz
/s/ Maria Carolina Ferreira Lacerda		Member of Board of Directors
Maria Carolina Ferreira Lacerda

 

II-6

 

SIGNATURE OF AUTHORIZED REPRESENTATIVE OF THE REGISTRANT IN THE UNITED STATES

 

Pursuant to the Securities Act of 1933, as amended, this registration statement has been signed by the undersigned in their capacity as the duly authorized representative of the registrant in the United States on April 9, 2020.

 

Authorized Representative in the U.S.
Puglisi & Associates
By:	/s/ Donald J Puglisi
	Name: Donald J Puglisi
	Title: Managing Director

 

II-7

 

Index to Exhibits

 

Exhibit	Document	Sequentially Numbered Page
(a)	Form of Amended and Restated Deposit Agreement
(d)	Opinion of counsel to the Depositary